CB Insights
Technology Market Intelligence
Technology Market Intelligence
Agent Capital is a health care venture capital firm focused on investing in novel therapeutics and innovative technology platforms that address unmet patient need.
Phone: 844-691-6233
204 Drakes Drum Drive
Bryn Mawr, 19010
Pennsylvania, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2019-07-12 | Pyxis Oncology | Series A | $22M | Flavin Ventures, Ipsen Group, Leaps by Bayer, and Longwood Fund |
| 2018-12-18 | Entrada Therapeutics | Series A | $59M | 5AM Ventures, MPM Capital, MRL Ventures, and Roche Venture Fund |
| 2018-08-13 | Orchard Therapeutics | Series C | $150M | ArrowMark Partners, Baillie Gifford & Co., Cormorant Asset Management, Cowen, Deerfield Management, Driehaus Capital Management, Foresite Capital, Ghost Tree Capital Group, Medison Ventures, Perceptive Advisors, RA Capital Management, RTW Investments, Sphera Global Healthcare, Temasek, and Venrock |
| 2018-07-16 | Pliant Therapeutics | Series B | $62.15M | Bessemer Trust, Cowen, Eventide Asset Management, Menlo Ventures, S-Cubed Capital, and Schroder Adveq |
| 2018-07-16 | Verge Genomics | Series A | $32M | ALS Investment Fund, OS Fund, Threshold Ventures, and WuXi Healthcare Ventures |
